FDA Clearance Tracker · P970003-S104
VNS THERAPY SYSTEM
Last checked: Nov 20, 2026Latest source record: Jul 23, 2009 (this decision)Source: openFDAMethods & limitations
Decided
Jul 23, 2009
Approved
Time to decision
239 days
Received Nov 26, 2008. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P970003-S104
- Device name
- VNS THERAPY SYSTEM
- Applicant
- LivaNova USA, Inc.
- Applicant location
- Houston, TX
- Received
- Nov 26, 2008
- Decided
- Jul 23, 2009
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol - OSB
- Original approval
- P970003
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.
Source documents
Other decisions for LivaNova USA, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P250013 · Decided Mar 18, 2026 · 327 days after receipt
Device type: Stimulator, hypoglossal nerve, implanted, apnea (MNQ) · Anesthesiology & Respiratory
4 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.